GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

HLK Biotec Holding Group AMHD · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

At a glance

Figures in USD, from our data supplier.

FY2016

Revenue

$8,329

FY2014FY2016

Net income

−$3,769

FY2014FY2016

Free cash flow

−$1,205

FY2014FY2016

Shareholders' equity

$51,919

FY2014FY2016

Income statement

Fiscal years

FY2016FY2015FY2014
Revenue$8,329$12,224$18,095
Gross profit$8,329$12,224$18,095
Operating income−$912−$3,118−$11,363
Net income−$3,769$1−$19,092
Diluted earnings per share-0.000.00-0.00

Balance sheet

At each fiscal year end

FY2016FY2015FY2014
Total assets$116,707$116,872$121,356
Total liabilities$64,788$61,184$65,669
Debt$16,540$42,327$65,669
Shareholders' equity$51,919$55,688$55,687
Shares outstanding6m6m6m

Cash flow

Fiscal years

FY2016FY2015FY2014
Cash from operations−$1,205$2,565−$16,528
Free cash flow−$1,205$2,565−$16,528

Latest quarters

By quarter end

Sept 2017Jun 2017Mar 2017Dec 2016Mar 2000Dec 1999Sept 1999
Revenue——$2,319$1,917$357,375——
Gross profit——$2,319$1,917−$121,697−$15,000−$116,314
Operating income−$641−$641−$1,032−$98−$569,468−$148,648−$427,643
Net income−$641−$641−$1,332−$567−$573,746−$158,581−$438,999
Diluted earnings per share-0.00-0.00-0.00-0.00-0.10-0.03-0.08
Total assets$112,380$113,021$113,662$116,707$1.3m$1.1m$985,785
Debt——$9,682$16,540$500,000$500,000$500,000
Shareholders' equity$49,305$48,614$50,587$51,919−$211,720−$311,179−$167,598

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-89.1%-75.1%—
Net income-84.6%-67.0%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin100.0%———
Operating margin-19.6%———
Net margin-18.3%———

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return0%400%100%200%2437%37839%54593%39838%5660%0%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 1000-to-1 reverse split · 23 Feb 2018
  • 100-to-1 reverse split · 12 Dec 2002

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.